EUVIMEDEUVIMED entdecken
Crossref

A Cyclized Bivalent Aptamer-Based Protein Degrader Targeting Receptor Tyrosine Kinases Overcomes Resistance to Inhibitors in Lung Cancer

Shanchao Wu, Xinyi Zhou, Lili Ai, Yanxue Shang, Yuping Yan, Zilong Zhao iD, Weihong Tan iD

ACS Nano · 12.08.2025 · 19 (31) · 28171-28185

DOI: 10.1021/acsnano.5c03120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 29.07.2025. Verfasst von Shanchao Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering, Apta…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Lung Neoplasms, Protein Kinase Inhibitors, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmLung NeoplasmsProtein Kinase InhibitorsCarcinoma, Non-Small-Cell LungAntineoplastic AgentsAptamers, NucleotideHumansAnimalsErbB ReceptorsMiceCell Line, TumorProto-Oncogene Proteins c-metErlotinib HydrochlorideMice, NudeCell ProliferationProteolysis

Stichwörter der Autor:innen

PROTACsaptamerdrug resistancelung cancerprotein degradation

Substanzen

Protein Kinase InhibitorsErbB ReceptorsAntineoplastic AgentsAptamers, NucleotideProto-Oncogene Proteins c-metErlotinib HydrochlorideEGFR protein, human

Autor:innen und Institutionen

  • Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering, Aptamer Engineering Center of Hunan Province, Hunan University, Changsha,…
  • Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.

ORCID-Profile: Zilong Zhao, Weihong Tan

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Wu, S., Zhou, X., Ai, L., Shang, Y., Yan, Y., Zhao, Z., & Tan, W. (2025). A Cyclized Bivalent Aptamer-Based Protein Degrader Targeting Receptor Tyrosine Kinases Overcomes Resistance to Inhibitors in Lung Cancer. ACS Nano, 19(31), 28171-28185. https://doi.org/10.1021/acsnano.5c03120

Vancouver

Wu S, Zhou X, Ai L, Shang Y, Yan Y, Zhao Z, et al. A Cyclized Bivalent Aptamer-Based Protein Degrader Targeting Receptor Tyrosine Kinases Overcomes Resistance to Inhibitors in Lung Cancer. ACS Nano. 2025;19(31):28171-28185. doi:10.1021/acsnano.5c03120

BibTeX
@article{Wu2025,
  author = {Wu, Shanchao and Zhou, Xinyi and Ai, Lili and Shang, Yanxue and Yan, Yuping and Zhao, Zilong and Tan, Weihong},
  title = {A Cyclized Bivalent Aptamer-Based Protein Degrader Targeting Receptor Tyrosine Kinases Overcomes Resistance to Inhibitors in Lung Cancer},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {31},
  pages = {28171--28185},
  doi = {10.1021/acsnano.5c03120}
}
Kostenlos starten →